… to heavy drinking and total alcohol consumption. The FDA approved extended-release
injectable naltrexone (Vivitrol) to treat people with alcohol dependence in 2006. In October 2010, …

… Combined pharmacotherapies and behavioral interventions for alcohol dependence: the …
for AUD, including alcohol withdrawal, as determined by Structured Clinical Interview for DSM-…

… -induced adaptations in CeA neurons and their behavioral implications in alcohol-dependent
and/or alcohol-withdrawn organisms. These ongoing studies may elucidate the mechanism…

… the disease—for example, “alcohol abuse” and “alcohol dependence” in the fourth edition
of … of alcohol misuse will continue to have both theoretical and clinical implications, steering …

… The findings of this clinical trial support the efficacy of CBM for treatment of alcohol use
disorder. Being safe and easy to implement, requiring only a computer and joystick, and needing …

… people with alcohol dependence [45]; 80% of WE cases are only diagnosed at post-mortem. …
-long implications for their ability to live independently. Alcohol dependence accompanied …

… Clinical evidence describes perturbation of the gut-liver crosstalk in non-alcoholic fatty
liver disease, alcoholic liver disease, and primary sclerosing cholangitis. In liver cirrhosis, a …

… to risk for alcoholism [57]. Genetic variations in different individuals affect the risk of … alcohol
dependence. For example, the allele ADH1 B*3 induces a more rapid metabolism of alcohol…

… a Patients with severe alcoholic hepatitis whose condition has not responded to …
clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic …

… alcohol abuse and alcohol dependence), compared with patients who received any other
medication for AUD. Although the preponderance of evidence suggests that acamprosate may …